Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial

2021 ◽  
Author(s):  
Assuntina G Sacco ◽  
Ruifeng Chen ◽  
Francis P Worden ◽  
Deborah J L Wong ◽  
Douglas Adkins ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Squamous Cell ◽  
Neck Squamous Cell Carcinoma ◽  
Phase 2 ◽  
Open Label ◽  
Multicentre Phase ◽  
Phase 2 Trial

Nivolumab treatment for oesophageal squamous-cell carcinoma: an open-label, multicentre, phase 2 trial

2017 ◽  
Vol 18 (5) ◽  
pp. 631-639 ◽  
Author(s):  
Toshihiro Kudo ◽  
Yasuo Hamamoto ◽  
Ken Kato ◽  
Takashi Ura ◽  
Takashi Kojima ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Phase 2 ◽  
Oesophageal Squamous Cell Carcinoma ◽  
Open Label ◽  
Multicentre Phase ◽  
Phase 2 Trial
Sign in / Sign up

Export Citation Format

Share Document